XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.
XFOREST Therapeutics has raised $6.1M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
XFOREST Therapeutics's investors include Takeda, ANRI, Miyako Capital, KSP, NEDO.
XFOREST Therapeutics is headquartered in Kyoto, Japan.
XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.
XFOREST Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"XFOREST Therapeutics — Funding & Investors." VCBacked, January 24, 2025, https://www.vcbacked.co/company/xforest-therapeutics. Accessed November 12, 2026.
VCBacked. (2025). XFOREST Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/xforest-therapeutics
{{cite web |title=XFOREST Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xforest-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at XFOREST Therapeutics? Request a listing update